Want to join the conversation?
$VRTX expects to provide net product revenue guidance for Orkambi during 2016. As of Dec. 31, more than 4,500 people had begun treatment in the U.S. since approval. $VRTX sees vast majority of eligible patients in the U.S. will begin treatment by end of 2016. $VRTX will recognize revenues from Orkambi sales in the U.S. and Germany in 2016.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.
$RAI has received a $47 billion take over offer from British tobacco giant British American Tobacco! This is huge!